Effect of Levamisole Supplementation on Tetanus Vaccination Response Rates in Hemodialysis Patients
Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
Levamisole as an immunomodulator drug has been demonstrated to improve the immune response to
Hepatitis B virus (HBV) vaccination in hemodialysis patients. The aim of this study was to
evaluate the effect of levamisole supplementation on tetanus-diphtheria (Td) vaccine response
rate in hemodialysis patients.